Article Correctness Is Author's Responsibility: From scorpion to immunotherapy: Repurposing nature’s toxin for CAR T

Scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T cells to target brain tumor cells, according to a preclinical study. The institution has also opened the first in-human clinical trial to use the therapy.